Measuring Biomarker Progress-Reference-Cited by-同舟云学术

Measuring Biomarker Progress

Published:2015-06-23 Issue:1 Volume:98 Page:2-5
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Wagner JA¹,Atkinson AJ²

Affiliation:

1. Takeda Pharmaceuticals International Co.; Cambridge Massachusetts USA

2. Department of Pharmacology, Feinberg School of Medicine; Northwestern University; Chicago Illinois USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpt.133/fullpdf

Reference16 articles.

1. The cerebrospinal fluid glucose concentration. Steady state and kinetic studies in patients with cryptococcal meningitis.;Atkinson;Am. Rev. Respir. Dis.,1969

2. Mortality and morbidity of patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.;Echt;N. Engl. J. Med.,1991

3. Surrogate end points in clinical trials: are we being misled?;Fleming;Ann. Intern. Med.,1996

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heart Failure: Is There an Ideal Biomarker?;Reviews in Cardiovascular Medicine;2023-11-09

2. Inductive database to support iterative data mining: Application to biomarker analysis on patient data in the Fight-HF project;Journal of Biomedical Informatics;2022-11

3. Untargeted Metabolomics Studies of H9c2 Cardiac Cells Submitted to Oxidative Stress, β-Adrenergic Stimulation and Doxorubicin Treatment: Investigation of Cardiac Biomarkers;Frontiers in Molecular Biosciences;2022-06-29

4. Toxicity and toxicokinetic considerations in product development and drug research;Pharmacokinetics and Toxicokinetic Considerations;2022

5. A Review of Emerging Biomarkers for Immune Checkpoint Inhibitors in Tumors of the Gastrointestinal Tract;Medical Science Monitor;2021-12-08